ARTICLE | Company News
Corgenix, GBI merging
August 5, 2003 7:00 AM UTC
Anti-phospholipid test developer and manufacturer CONX and diagnostics company Genesis Bioventures (GBI) signed a letter of intent to merge. GBI will issue 14 million shares for ownership of CONX, val...